Evidence map›Paper›PMID 30009541›Full record

ArticleThe Prostate2018

Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors.

Natalie C DuPre, Richard Flavin, Karen S Sfanos, Robert H Unger, Samantha To, Elizaveta Gazeeva, Michelangelo Fiorentino, Angelo M De Marzo, Jennifer R Rider, Lorelei A Mucci and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Prostate, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Prostate carcinogenesis: inflammatory storms.Nature reviews. Cancer · 2020
    Review
  10. Article
  11. Obesity, Inflammation, and Prostate Cancer.Journal of clinical medicine · 2019
    Review
  12. Short histological kaleidoscope - recent findings in histology. Part II.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Natalie C DuPreDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0003-4587-0467
Richard FlavinDepartment of Histopathology, St. James's Hospital and Trinity College, Dublin, Ireland.
Karen S SfanosDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Massachusetts.ORCID 0000-0002-7015-3059
Robert H UngerDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Samantha ToGlobal Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
Elizaveta GazeevaDepartment of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Michelangelo FiorentinoDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Angelo M De MarzoDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Massachusetts.
Jennifer R RiderDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.
Lorelei A MucciDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Transdisciplinary Prostate Cancer Partnership(ToPCaP)
Harvard University · USJohns Hopkins University · USBoston University · USBrigham and Women's Hospital · USTrinity College Dublin · IE

Funding

Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate CanceP50CA090381 · NCI · DANA-FARBER CANCER INSTITUTE · PI KANTOFF, PHILIP W · 2002 to 2017
$36.2M
Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
Cancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Lorelei Mucci, Walter C. Willett · 2017 to 2026
$17.0M
Cancer Epidemiology Cohort in Male Health ProfessionalsUM1CA167552 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2012 to 2016
$11.5M
Growth Factors and Lethal Prostate Cancer SignatureR01CA141298 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI STAMPFER, MEIR · 2010 to 2013
$2.2M
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer ProgressionR01CA136578 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI MUCCI, LORELEI · 2009 to 2013
$1.7M
NCI NIH HHS P50 CA090381NCI NIH HHS R01 CA136578NCI NIH HHS R01CA136578NCI NIH HHS R01 CA141298NCI NIH HHS R01CA141298NCI NIH HHS T32 CA009001NCI NIH HHS T32 CA09001NCI NIH HHS U01 CA167552NCI NIH HHS UM1 CA167552
6 · The paper itself

Abstract

backgroundCorpora amylacea are amyloid bodies commonly found adjacent to damaged prostate epithelium. Little is known about their formation or function. The current study sought to characterize corpora amylacea in prostate tissue and to describe their relationship with clinical, histological, molecular, and lifestyle factors, especially with chronic inflammation which is associated with aggressive disease.

methodsWe studied a cohort of 355 men with prostate cancer and tissue specimens from the Health Professionals Follow-Up Study. Pathologists examined H&E slides and undertook a standardized review for histologic data and inflammation. Trained observers counted corpora amylacea within the benign and predominately tumor areas. Immunohistochemistry biomarkers were available from tissue microarrays. We used multivariable logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) to assess associations of chronic inflammation, clinical, histological, molecular, and lifestyle factors with the presence of corpora amylacea.

resultsCorpora amylacea were present in benign tissue area for 298 men (84%). Specimens with moderate-to-severe chronic inflammation were more likely to have corpora amylacea in benign regions (OR = 5.4 95%CI 1.9, 15.6). Moreover, corpora amylacea were more common in men with higher body mass index (OR = 1.13 95%CI 1.01, 1.26). In contrast, Gleason grade (OR = 0.4 95%CI 0.2, 0.8), proliferation index (OR = 0.6 95%CI 0.3, 1.2) and the presence of the TMPRSS2:ERG fusion (OR = 0.4 95%CI 0.2, 0.8) were inversely associated with corpora amylacea presence. TURP specimens were less likely to have corpora amylacea than prostatectomy specimens (OR = 0.12 95%CI 0.03, 0.47). Age, PSA, stage, biomarkers of angiogenesis and PTEN, and vasectomy were not significantly associated with corpora amylacea.

conclusionCorpora amylacea were common among men with prostate cancer and were associated with pro-inflammatory factors, some markers of less aggressive disease, and lack of the TMPRSS2:ERG fusion.

Indexed as

AdultAgedCohort StudiesHumansImmunohistochemistryLife StyleMaleMiddle AgedNeoplasm GradingPlaque, AmyloidProstatectomyProstatic Neoplasmscorpora amylaceaepidemiologyinflammationprostateTMPRSS2:ERG

Identifiers

PMID30009541
PMCPMC6501556
OpenAlexW2884076176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.